trazodone has been researched along with Delirium in 14 studies
Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
Delirium: A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to examine the effects of suvorexant on delirium prevention in a real-world setting." | 7.96 | Real-World Preventive Effects of Suvorexant in Intensive Care Delirium: A Retrospective Cohort Study. ( Araki, T; Hashioka, S; Hayashida, M; Inagaki, M; Ito, T; Izuhara, HK; Izuhara, M; Kimura, T; Miura, S; Nagahama, M; Otsuki, K; Saito, Y; Sato, K; Tsuchie, K; Tsumoto, S; Wake, R, 2020) |
| "Three bulimic patients with major depressive episodes developed delirium after trazodone administration." | 7.67 | Trazodone-induced delirium in bulimic patients. ( Damlouji, NF; Ferguson, JM, 1984) |
| "This study aimed to examine the effects of suvorexant on delirium prevention in a real-world setting." | 3.96 | Real-World Preventive Effects of Suvorexant in Intensive Care Delirium: A Retrospective Cohort Study. ( Araki, T; Hashioka, S; Hayashida, M; Inagaki, M; Ito, T; Izuhara, HK; Izuhara, M; Kimura, T; Miura, S; Nagahama, M; Otsuki, K; Saito, Y; Sato, K; Tsuchie, K; Tsumoto, S; Wake, R, 2020) |
| "Trazodone can be a candidate drug as one of the first line drugs for delirium." | 3.88 | First- and second-line pharmacological treatment for delirium in general hospital setting-Retrospective analysis. ( Iwamoto, T; Mifune, Y; Morita, Y; Nojima, S; Wada, K, 2018) |
| " In this report, we describe a 15-year-old adolescent girl who experienced continued delirium 5 days after an overdose of quetiapine, trazodone, and clonidine." | 3.76 | Prolonged delirium after quetiapine overdose. ( Pedapati, EV; Rhyee, SH; Thompson, J, 2010) |
| "Three bulimic patients with major depressive episodes developed delirium after trazodone administration." | 3.67 | Trazodone-induced delirium in bulimic patients. ( Damlouji, NF; Ferguson, JM, 1984) |
| "After multivariate analysis, dehydration (0." | 1.56 | Reversibility of delirium in Ill-hospitalized cancer patients: Does underlying etiology matter? ( Amano, K; Iwase, S; Kaneishi, K; Maeda, I; Matsuda, Y; Morita, T; Ogawa, A; Sakashita, A; Watanabe, H; Yamauchi, T; Yoshiuchi, K, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Ohsako, N | 1 |
| Hashimoto, T | 1 |
| Shiko, Y | 1 |
| Kawasaki, Y | 1 |
| Nakagawa, M | 1 |
| Okuma, T | 1 |
| Kurata, T | 1 |
| Suzuki, H | 1 |
| Ishige, M | 1 |
| Kikuchi, S | 1 |
| Matsuda, Y | 1 |
| Maeda, I | 2 |
| Morita, T | 1 |
| Yamauchi, T | 1 |
| Sakashita, A | 1 |
| Watanabe, H | 1 |
| Kaneishi, K | 1 |
| Amano, K | 2 |
| Iwase, S | 2 |
| Ogawa, A | 2 |
| Yoshiuchi, K | 2 |
| Izuhara, M | 1 |
| Izuhara, HK | 1 |
| Tsuchie, K | 1 |
| Araki, T | 1 |
| Ito, T | 1 |
| Sato, K | 1 |
| Miura, S | 1 |
| Otsuki, K | 1 |
| Nagahama, M | 1 |
| Hayashida, M | 1 |
| Hashioka, S | 1 |
| Wake, R | 1 |
| Kimura, T | 1 |
| Tsumoto, S | 1 |
| Saito, Y | 1 |
| Inagaki, M | 1 |
| Inoue, S | 1 |
| Uemura, K | 1 |
| Tanimukai, H | 1 |
| Hatano, Y | 1 |
| Yokomichi, N | 1 |
| Tagami, K | 1 |
| Wada, K | 1 |
| Morita, Y | 1 |
| Iwamoto, T | 1 |
| Mifune, Y | 1 |
| Nojima, S | 1 |
| Freter, S | 1 |
| Koller, K | 1 |
| Dunbar, M | 1 |
| MacKnight, C | 1 |
| Rockwood, K | 1 |
| Rhyee, SH | 1 |
| Pedapati, EV | 1 |
| Thompson, J | 1 |
| Inouye, SK | 1 |
| Damlouji, NF | 1 |
| Ferguson, JM | 1 |
| Lennkh, C | 1 |
| Fischer, P | 1 |
| Küfferle, B | 1 |
| Kasper, S | 1 |
| Okamoto, Y | 1 |
| Matsuoka, Y | 1 |
| Sasaki, T | 1 |
| Jitsuiki, H | 1 |
| Horiguchi, J | 1 |
| Yamawaki, S | 1 |
| Anfinson, T | 1 |
| Goldberg, RJ | 1 |
| Huk, M | 1 |
| Figiel, GS | 1 |
| Krishnan, KR | 1 |
| Breitner, JC | 1 |
| Nemeroff, CB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Trazodone vs. Quetiapine for the Treatment of ICU Delirium: A Prospective Observational Pilot Study[NCT05307003] | 60 participants (Anticipated) | Observational | 2023-04-01 | Recruiting | |||
| Comparison of Trazodone vs Quetiapine vs Placebo for the Treatment of ICU Delirium: A Randomized Controlled Trial (The TraQ Study)[NCT05085808] | Phase 4 | 30 participants (Anticipated) | Interventional | 2024-03-01 | Not yet recruiting | ||
| A Randomized Controlled Trial To Assess Risk of Delirium in Older Adults Undergoing Hip Fracture Surgery With Spinal or General Anesthesia[NCT02190903] | 15 participants (Actual) | Interventional | 2013-10-31 | Completed | |||
| Evaluation of the CogMe Technology Platform for the Prevention and Early Detection of Delirium Among Older Patients in an Acute Hospital Setting: A Proof of Concept Study[NCT05311761] | 100 participants (Anticipated) | Interventional | 2022-03-01 | Recruiting | |||
| Multicentric, Single Blind, Randomized Controlled Trial on Enteral Sedation Versus Intravenous Sedation in Critically Ill High-risk ICU Patients[NCT01360346] | Phase 3 | 300 participants (Anticipated) | Interventional | 2012-01-31 | Recruiting | ||
| Tailored Patient Management Guided With Absolute Cerebral Oximetry to Prevent Neurocognitive Injury in Elderly Patients Undergoing Cardiac Surgery.[NCT00991328] | Phase 3 | 15 participants (Actual) | Interventional | 2009-09-30 | Terminated (stopped due to low enrollment) | ||
| Non-Invasive Brain Stimulation and Delirium[NCT03518996] | 0 participants (Actual) | Interventional | 2018-09-01 | Withdrawn (stopped due to No Participants Enrolled) | |||
| HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial[NCT04833023] | Phase 3 | 72 participants (Anticipated) | Interventional | 2022-05-18 | Recruiting | ||
| Continuous Cerebral Autoregulation Monitoring to Reduce Brain Injury From Cardiac Surgery[NCT00981474] | 460 participants (Actual) | Interventional | 2009-09-01 | Completed | |||
| Dexmedetomidine and IV Acetaminophen for the Prevention of Postoperative Delirium Following Cardiac Surgery in Adult Patients 60 Years of Age and Older[NCT02546765] | Phase 4 | 140 participants (Actual) | Interventional | 2015-10-31 | Completed | ||
| Effects of Two Different Anesthesia-analgesia Methods on the Incidence of Postoperative Delirium: a Multicenter, Randomized Controlled Trial[NCT01661907] | 1,800 participants (Actual) | Interventional | 2011-11-21 | Completed | |||
| Prevention of Delirium in Inpatients Utilizing Melatonin[NCT02654314] | Phase 3 | 277 participants (Actual) | Interventional | 2016-07-31 | Terminated (stopped due to Lack of resources to complete the study. Descriptive statistics for the outcome measures collected are provided.) | ||
| Cukurova University Faculty of Medicine[NCT02360982] | 120 participants (Actual) | Observational | 2012-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Delirium will be assessed by the Confusion Assessment Method Instrument (CAM), a validated method of assessing delirium based on the presence of both (1) an acute onset of signs and symptoms with a fluctuating course AND (2) inattention; PLUS (3) disorganized thinking OR (4) an altered level of consciousness. (NCT02190903)
Timeframe: Up to 5 days post hip fracture surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| General Endotracheal Anesthesia | 2 |
| Regional (Spinal) Anesthesia | 0 |
Subject developed acute kidney injury within 7 days after surgical procedure. Based on Kidney disease: Improving Global Outcomes (KDIGO) classification system. (NCT00981474)
Timeframe: 7 days after surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 56 |
| Intervention | 62 |
The composite neurological outcome was composed of clinical stroke, or new ischemic lesions detected on postoperative brain diffusion weighted magnetic resonance imaging(DWI), or cognitive decline from baseline to 4-6 weeks after surgery. (NCT00981474)
Timeframe: Up to 6 weeks post-operative
| Intervention | Participants (Count of Participants) |
|---|---|
| Usual Care Group (Control) | 79 |
| Autoregulation Group | 70 |
Procedural insertion of intra-aortic balloon pump within 7 days after surgical procedure (NCT00981474)
Timeframe: 7 days after surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 19 |
| Intervention | 14 |
Subjects need for mechanical lung ventilation more than 24 hours after planned surgical procedure. (NCT00981474)
Timeframe: Up to 28 days after surgery.
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 22 |
| Intervention | 13 |
Subject death within 28 days after surgical procedure (NCT00981474)
Timeframe: 28 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 12 |
| Intervention | 5 |
Use of multiple inotropic drugs greater than 24 hours after the planned surgical procedure until discharge from the hospital. (NCT00981474)
Timeframe: 7 days after surgery
| Intervention | participants (Number) |
|---|---|
| Usual Care Group (Control) | 13 |
| Autoregulation Group | 6 |
Subject diagnosis of multisystem organ failure after surgery. (NCT00981474)
Timeframe: Up to 28 days after surgery.
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 7 |
| Intervention | 2 |
Subjects requiring new renal replacement therapy prior to discharge from hospital (NCT00981474)
Timeframe: Up to 28 days after surgery.
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 6 |
| Intervention | 4 |
Clinical diagnosis of postoperative atrial fibrillation from date of surgical procedure to discharge from the hospital. (NCT00981474)
Timeframe: Up to 28 days after surgery.
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 89 |
| Intervention | 79 |
Assessed with Confusion Assessment Method or Confusion Assessment Method-ICU along with adjudication by team of experts (NCT00981474)
Timeframe: Postoperative days 1-4
| Intervention | Participants (Count of Participants) |
|---|---|
| Usual Care Group (Control) | 34 |
| Autoregulation Group | 19 |
Clinical diagnosis of sepsis from time of surgical procedure to discharge from the hospital. (NCT00981474)
Timeframe: Up to 28 days after surgery.
| Intervention | Participants (Count of Participants) |
|---|---|
| Control | 7 |
| Intervention | 2 |
Duration of delirium will be analyzed, measured from 24 hours post-operation and daily until discharge. Additional measurements will be made at 1 month and 1 year after discharge. Delirium will be defined as an acute change in pre-operative baseline condition with additional features of inattention and either disorganized thinking and altered loss of consciousness, as defined by the Confusion Assessment Method (CAM). (NCT02546765)
Timeframe: Participants will be followed for the duration of the hospital stay, an average of 6 days, and at 1 month and 1- year following the date of surgery
| Intervention | days (Median) |
|---|---|
| Acetaminophen and Dexmedetomidine | 1 |
| Acetaminophen and Propofol | 1 |
| Placebo and Dexmedetomidine | 1 |
| Placebo and Propofol | 3 |
The follow up incidence of cognitive dysfunction will be analyzed at 1 month after discharge. T-MoCA is Telephone Montreal Cognitive Assessment Scale (MOCA). The T-MoCA is scored out of 22. The minimum score is 0 (worst) and maximum score is 22 (best). T-MOCA is converted back to 30 (full MOCA) with the help of conversion algorithms to a full MOCA.Example: 19/22 converts back to 30 by performing the following equation: (19×30) ÷ 22. The total converted score is 25.9 or 26/30 which is considered in the normal range. (NCT02546765)
Timeframe: Patients will be assessed for cognitive dysfunction with T-MOCA at 1 month following the date of surgery
| Intervention | units on a scale (Median) |
|---|---|
| Acetaminophen and Dexmedetomidine | 17 |
| Acetaminophen and Propofol | 18 |
| Placebo and Dexmedetomidine | 19 |
| Placebo and Propofol | 18 |
Defined by the number of days admitted in the hospital following the completion of surgery. (NCT02546765)
Timeframe: Measured in days admitted in the hospital, an average of 6 days
| Intervention | days (Median) |
|---|---|
| Acetaminophen and Dexmedetomidine | 8 |
| Acetaminophen and Propofol | 8 |
| Placebo and Dexmedetomidine | 9 |
| Placebo and Propofol | 8 |
Defined by the number of days admitted in the ICU prior to transfer to the general cardiac surgical floor (NCT02546765)
Timeframe: Measured in days admitted in the ICU, an average of 2 days
| Intervention | hours (Median) |
|---|---|
| Acetaminophen and Dexmedetomidine | 28.8 |
| Acetaminophen and Propofol | 30.3 |
| Placebo and Dexmedetomidine | 49.1 |
| Placebo and Propofol | 29.3 |
Incidence of delirium will be analyzed between patients treated with and without IV acetaminophen, measured from 24 hours post-operation and daily until discharge. Delirium will be defined as an acute change in pre-operative baseline condition with additional features of inattention and either disorganized thinking and altered loss of consciousness, as defined by the Confusion Assessment Method (CAM). (NCT02546765)
Timeframe: Participants will be followed for the duration of the hospital stay, an average of 5 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Acetaminophen and Dexmedetomidine | 2 |
| Acetaminophen and Propofol | 4 |
| Placebo and Dexmedetomidine | 8 |
| Placebo and Propofol | 9 |
MoCA scores at discharge will be reported in order to assess the occurrence of postoperative cognitive decline. Blinded study staff trained in administering the assessments will collect the data. MoCA is scored on a scale from 0 [worst] to 30 [best]; ǂA MoCA score of 24 would be equivalent to an Mini-Mental State Examination (MMSE) of about 27 or 28. Depending on education and peak intellectual attainment, such a score could be consistent with being either cognitively normal, or having very early mild cognitive impairment. Certainly such a person would be capable of living independently in the community and managing most or all of their affairs. (NCT02546765)
Timeframe: On the day of discharge, an average of 6 days
| Intervention | score on a scale (Median) |
|---|---|
| Acetaminophen and Dexmedetomidine | 23 |
| Acetaminophen and Propofol | 24 |
| Placebo and Dexmedetomidine | 24 |
| Placebo and Propofol | 23 |
Defined by the amount of additional opioid (IV morphine or hydromorphone) and oral acetaminophen medications required in the first 48 hours postoperatively. Values will be converted to morphine equivalents for analysis. Total morphine equivalent is calculated as the sum of (fentanyl dose x 100)+(hydromorphone dose x 4)+morphine dose+(oxycodone dose x 1.5) (NCT02546765)
Timeframe: Participants will be followed for the first 48 hours postoperatively.
| Intervention | mcg (Median) |
|---|---|
| Acetaminophen and Dexmedetomidine | 10050 |
| Acetaminophen and Propofol | 12611 |
| Placebo and Dexmedetomidine | 11382 |
| Placebo and Propofol | 12616 |
Severity of delirium will be analyzed, measured from 24 hours post-operation and daily until discharge. The worst severity experienced while in the hospital will be analyzed. Delirium will be defined as an acute change in pre-operative baseline condition with additional features of inattention and either disorganized thinking and altered loss of consciousness, as defined by the Confusion Assessment Method Severity Score (CAM-S, Confusion Assessment Method-Severity). range 0 [best/no delirium] to 19 [worst]; Minimal Clinical Important Difference (MCID) 2 points (NCT02546765)
Timeframe: Participants will be followed for the duration of the hospital stay, an average of 6 days
| Intervention | units on a scale (Median) |
|---|---|
| Acetaminophen and Dexmedetomidine | 10 |
| Acetaminophen and Propofol | 8 |
| Placebo and Dexmedetomidine | 6 |
| Placebo and Propofol | 9 |
Days utilizing restraints is defined as the number of days restraints were applied because of delirium in the first 14 days of hospitalization. (NCT02654314)
Timeframe: length of hospitalization, not to exceed 14 days
| Intervention | days (Median) |
|---|---|
| Melatonin | 0 |
| Cellulose Microcrystylline | 0 |
Delirium is defined by the Short Form Confusion Assessment Method (CAM). There must be inattention and either an acute or fluctuating course plus either disorganized thinking or an altered level of consciousness to be diagnosed with delirium. Presented is a count of individuals with reported delirium during hospitalization. (NCT02654314)
Timeframe: length of hospitalization, not to exceed 14 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Melatonin | 2 |
| Cellulose Microcrystylline | 8 |
Length of stay is defined as the total time hospitalized for the acute illness (in days). (NCT02654314)
Timeframe: from day of admission to completion of acute care, not to exceed 30 days
| Intervention | days (Mean) |
|---|---|
| Melatonin | 4.58 |
| Cellulose Microcrystylline | 4.71 |
Number of delirium anti-psychotic drug doses given for symptoms of delirium. Presented are the number of doses per days of hospitalization. (NCT02654314)
Timeframe: length of hospitalization, not to exceed 14 days
| Intervention | number of doses per days of hospitalizat (Median) |
|---|---|
| Melatonin | 0 |
| Cellulose Microcrystylline | 0 |
1 review available for trazodone and Delirium
| Article | Year |
|---|---|
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
Delirium in older persons.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dementia; Diagnosis, Differential; Humans | 2006 |
2 trials available for trazodone and Delirium
| Article | Year |
|---|---|
Translating Delirium Prevention Strategies for Elderly Adults with Hip Fracture into Routine Clinical Care: A Pragmatic Clinical Trial.
Topics: Aged; Aged, 80 and over; Analgesics; Anti-Dyskinesia Agents; Dehydration; Delirium; Female; Haloperi | 2017 |
Trazodone in the treatment of delirium.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Delirium; Female; Humans; Male; M | 1999 |
Trazodone in the treatment of delirium.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Delirium; Female; Humans; Male; M | 1999 |
Trazodone in the treatment of delirium.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Delirium; Female; Humans; Male; M | 1999 |
Trazodone in the treatment of delirium.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Delirium; Female; Humans; Male; M | 1999 |
11 other studies available for trazodone and Delirium
| Article | Year |
|---|---|
Pharmacotherapy for elderly patients with delirium in a general ward setting: A retrospective study.
Topics: Aged; Antipsychotic Agents; Delirium; Humans; Patients' Rooms; Retrospective Studies; Trazodone | 2022 |
Reversibility of delirium in Ill-hospitalized cancer patients: Does underlying etiology matter?
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cancer Care Facilities; Comorbidity; Dehydration; Del | 2020 |
Real-World Preventive Effects of Suvorexant in Intensive Care Delirium: A Retrospective Cohort Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azepines; Child; Child, Preschool; Critical Care; Deliri | 2020 |
Low-Dose Trazodone for Delirium in Patients with Cancer Who Received Specialist Palliative Care: A Multicenter Prospective Study.
Topics: Aged; Delirium; Humans; Japan; Neoplasms; Palliative Care; Prospective Studies; Trazodone | 2021 |
Low-Dose Trazodone for Delirium in Patients with Cancer Who Received Specialist Palliative Care: A Multicenter Prospective Study.
Topics: Aged; Delirium; Humans; Japan; Neoplasms; Palliative Care; Prospective Studies; Trazodone | 2021 |
Low-Dose Trazodone for Delirium in Patients with Cancer Who Received Specialist Palliative Care: A Multicenter Prospective Study.
Topics: Aged; Delirium; Humans; Japan; Neoplasms; Palliative Care; Prospective Studies; Trazodone | 2021 |
Low-Dose Trazodone for Delirium in Patients with Cancer Who Received Specialist Palliative Care: A Multicenter Prospective Study.
Topics: Aged; Delirium; Humans; Japan; Neoplasms; Palliative Care; Prospective Studies; Trazodone | 2021 |
First- and second-line pharmacological treatment for delirium in general hospital setting-Retrospective analysis.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Delirium; Female; Hospitals, General; Humans; Japan; | 2018 |
First- and second-line pharmacological treatment for delirium in general hospital setting-Retrospective analysis.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Delirium; Female; Hospitals, General; Humans; Japan; | 2018 |
First- and second-line pharmacological treatment for delirium in general hospital setting-Retrospective analysis.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Delirium; Female; Hospitals, General; Humans; Japan; | 2018 |
First- and second-line pharmacological treatment for delirium in general hospital setting-Retrospective analysis.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Delirium; Female; Hospitals, General; Humans; Japan; | 2018 |
Prolonged delirium after quetiapine overdose.
Topics: Adolescent; Antipsychotic Agents; Cholinergic Antagonists; Clonidine; Cytochrome P-450 CYP3A; Deliri | 2010 |
Trazodone-induced delirium in bulimic patients.
Topics: Adolescent; Adult; Delirium; Depressive Disorder; Feeding and Eating Disorders; Female; Hallucinatio | 1984 |
Occurrence of trazodone-induced delirium.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cerebrovascular Disorders; Deliri | 1998 |
Pharmacologic management of aggression and violence.
Topics: Adrenergic beta-Antagonists; Aggression; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Contr | 1992 |
Serotonin syndrome from trazodone and buspirone.
Topics: Aged; Buspirone; Delirium; Humans; Male; Myoclonus; Serotonin; Trazodone | 1992 |
Radiologic correlates of antidepressant-induced delirium: the possible significance of basal-ganglia lesions.
Topics: Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Basal Ganglia; Basal Ganglia Diseases | 1989 |